Sign Up to like & get
recommendations!
0
Published in 2022 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.25019
Abstract: Lung carcinoma remains one of the most frequent and aggressive human neoplasms. Fortunately, in the last decades, the increasing knowledge of the molecular mechanisms leading to cancer development has allowed the use of targeted therapies…
read more here.
Keywords:
molecular testing;
lung carcinoma;
non small;
testing non ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Eurasian Economic Review"
DOI: 10.1007/s40822-020-00163-0
Abstract: The main purpose of this article is to detail and supply a stress-testing framework at the individual level that investigates the impact of COVID-19 scenarios on non-financial firms’ probability of default as regards domestic and…
read more here.
Keywords:
stress testing;
non financial;
testing non;
stress ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "British Medical Journal"
DOI: 10.1136/bmj.k3710
Abstract: As others have said, routine screening with liver function tests needs to be stopped, but after the result is out, what should we do?12 As a general practitioner, I found Byrne and colleagues’ article helpful,…
read more here.
Keywords:
keep testing;
resources keep;
testing non;
nhs lacks ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "BioMed Research International"
DOI: 10.1155/2019/6832909
Abstract: An important harmonization effort was produced by the scientific community to standardize both the preanalytical and interpretative phases of programmed death-ligand 1 (PD-L1) immunohistochemical (IHC) testing in non-small-cell lung cancer (NSCLC). This analysis is crucial…
read more here.
Keywords:
non small;
testing non;
cell lung;
lung cancer ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2022.664710
Abstract: Several neurological disorders may be amenable to treatment with gene-targeting therapies such as antisense oligonucleotides (ASOs) or viral vector-based gene therapy. The US FDA has approved several of these treatments; many others are in clinical…
read more here.
Keywords:
neurology;
modified sensory;
neurological disorders;
testing non ... See more keywords